Skip to main content
TipRanks
Go Ultimate75% OFF

Else Nutrition Holdings (0YL1) AI Stock Analysis

0 Followers
DE:0YL1

Else Nutrition Holdings

(Frankfurt:0YL1)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Plant‑based, specialty nutrition positioningElse’s focus on dairy‑ and soy‑free toddler and child nutrition targets a structural, growing niche (plant-based, allergy-friendly formulations). This specialization supports durable differentiation, higher consumer stickiness for specialty products, and long‑term category tailwinds versus generic CPG offerings.
Negative Factors
Negative gross and net marginsNegative gross margins indicate unit economics that currently destroy value, undermining sustainable scaling. Persistently negative margins limit ability to invest in marketing or distribution without worsening cash burn, and create structural barriers to achieving profitability absent product, pricing, or cost changes.

Else Nutrition Holdings (0YL1) vs. iShares MSCI Germany ETF (EWG)

-100%-50%0%50%100%DE:0YL1-98.11%EWG+9.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 235.53K
Dividend Yield
―
Average Volume (3M)
3,963
Price to Earnings (P/E)
-0.0
Beta (1Y)
-27.42
Revenue Growth
-31.78%
EPS Growth
77.42%
Country
Germany
Employees
12
Sector
Consumer Defensive
Sector Strength
62
Industry
Packaged Foods

Else Nutrition Holdings Business Overview & Revenue Model

Company Description

Else Nutrition Holdings Inc. focuses on the creation, production, and distribution of a variety of food and nutritional items for consumers ranging from infants and toddlers to children and adults. The company primarily operates within the North Amer...

Else Nutrition Holdings Earnings Call Summary

Earnings Call Date:Sep 16, 2025(Q2-2025)|% Change Since:-99.48%|Next Earnings Date:Aug 29, 2019
Earnings Call SentimentNeutral

Else Nutrition has shown significant progress in reducing costs and improving operational efficiency, with promising advancements in regulatory pathways and international growth. However, challenges such as revenue decline, negative gross margin, and inventory constraints have impacted performance.

Positive Updates

Expansion of Kids Ready-to-Drink Products
Else Nutrition's kids ready-to-drink products expanded to approximately 1,000 Walmart stores, showing significant market penetration and consumer interest.

Negative Updates

Revenue Decline
Total revenues for Q2 2025 were $1.5 million compared to $2.6 million in Q2 2024, mainly due to inventory constraints.

Company Guidance

During Else Nutrition's 2025 Second Quarter Conference Call, CEO Hamutal Yitzhak outlined several key metrics and strategic initiatives demonstrating the company's progress. The quarter saw total revenues of $1.5 million, a decrease from $2.6 million in Q2 2024, primarily due to inventory constraints and seasonal sales fluctuations. Gross profit faced a loss of $55,000, translating to a negative gross margin of -3.7%, affected by additional revenue reductions of CAD 270,000. Despite these challenges, operating expenses were significantly reduced by 60% year-over-year to $1.3 million, leading to a narrowed operating loss of $1.4 million, an improvement of 55% from the previous year. Else is targeting cash flow positivity by late 2026 or early 2027, focusing on supply chain optimization, regulatory advancements, and strategic partnerships to enhance growth and profitability.

Else Nutrition Holdings Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

DE:0YL1 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TSE:JWELTSE:JWEL69NeutralCAD 1.90B24.3015.93%2.06%14.96%35.61%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
TSE:NPRATSE:NPRA49NeutralCAD 35.31M-24.7830.14%―32.91%55.73%
TSE:BUTSE:BU40UnderperformCAD 10.66M-0.74338.06%―556.85%-11.49%
TSE:HBFGTSE:HBFG40UnderperformCAD 239.62M-12.38-311.77%―82.33%-570.45%

* Consumer Defensive Sector Average

Performance Comparison

0%200%400%600%DE:0YL1TSE:BUTSE:JWELTSE:HBFGTSE:NPRADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:0YL1 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:0YL1Else Nutrition Holdings Inc0.01-0.67-98.11%
TSE:BUBurcon Nutrascience Corporation0.84-1.16-58.00%
TSE:JWELJamieson Wellness45.6911.6334.15%
TSE:HBFGHappy Belly Food Group Inc1.44-0.29-16.76%
TSE:NPRANepra Foods, Inc.0.280.16133.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.